У нас вы можете посмотреть бесплатно PURE EXTRACTS DELINEATES STUDY ON PSILOCYBIN ORAL TABLETS, CAPSULES AND NASAL GEL или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
PURE EXTRACTS DELINEATES STUDY ON PSILOCYBIN ORAL TABLETS, CAPSULES AND NASAL GEL - January 14, 2021 - RICH TV LIVE - Pure Extracts Technologies Corp . (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it has delineated the timetable and milestones for its study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. The study with be conducted at the Toronto Institute of Pharmaceutical Technology (“TIPT”) by Dr. Alexander MacGregor, a key scientific advisor to the Company. The study will focus on formulating, manufacturing and clinical bioavailability testing of rapid onset psilocybin dosage forms that could be used in future efficacy clinical trials by both Pure Extracts and its pharmaceutical customers. Clinical batch manufacturing, packaging and labelling are all included in the study as is conformity testing and stability testing (including both long-term and accelerated). The study will conform to both Canadian Good Manufacturing Practice (“GMP”) and Good Clinical Practice (“GCP”) standards. The key milestones in the 250-day timeline for the study on psilocybin immediate release tablets and nasal gel include the following: Sourcing and procurement of medicinal ingredients, excipients & packaging materials Raw Material Testing Formulation and Manufacturing Process Development, Stability Testing Clinical Batch Manufacturing Quality Control Release Testing Shipping of Clinical Batches to CRO Pure Extracts CEO, Ben Nikolaevsky, remarked, “We are excited about the R&D progress we are going to make with TIPT over the next 6 – 8 months while waiting to receive our Dealer’s License from Health Canada. We will be well prepared for our move into the controlled substances world of psychedelics and will have advanced knowledge regarding psilocybin and its associated novel delivery mechanisms.” #pureextracts #psychedelics #richtvlive JOIN RICH TV LIVE TRADING CLUB HERE - www.richpicksdaily.com Join The RICH TV LIVE CHANNEL MEMBERSHIP - / @richtvlive Subscribe - / richtvlive Visit - http://www.richtvlive.com/ & www.richpicksdaily.com a community for stocks, news, and trending topics. #richtvlive #stockmarket #money Popular Uploads - https://goo.gl/tbvXGg Most Recent Upload - https://goo.gl/unKXBy YouTube Channel Page - https://goo.gl/yUdG7w Subscribe - / richtvlive Rich TV Live Playlist - https://goo.gl/e116JF RICH TV LIVE TOP 10 STOCKS Playlist - • TOP 10 STOCKS MONTHLY Disclaimer RICH TV LIVE INC. company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RICH TV LIVE reports company profiles or other investor relations materials and presentations are subject to change. RICH TV LIVE and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. RICH TV LIVE INC. sponsored $5,000 CAD per month for video presentation services. Investing is inherently risky. RICH TV LIVE is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov/Canadian CSA https://www.securities-administrators....